Company profile for Veristat

NEW Drugs in Dev: 2
PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Veristat is a consultative Clinical Research Organization (CRO) that is committed to partnering with clients in order to advance their therapies through the clinical development and regulatory submission process. Ultimately, we guide our clients to market success so that their therapies become available to improve and save people’s lives. Veristat is the only CRO that is committed to building TRUE Partnerships with clients....
Veristat is a consultative Clinical Research Organization (CRO) that is committed to partnering with clients in order to advance their therapies through the clinical development and regulatory submission process. Ultimately, we guide our clients to market success so that their therapies become available to improve and save people’s lives. Veristat is the only CRO that is committed to building TRUE Partnerships with clients. You can have all the medical, scientific, clinical and statistical expertise in the world, but if you can’t work well together, you will not achieve success. At Veristat, building TRUE Partnerships is what makes us successful. A TRUE Partnership is built upon a foundation of: Trust through transparency, Respect of culture, Understanding of goals and expectations, Evolving for change.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2801 Slater Road, Suite 100 Morrisville, NC 27560
Telephone
Telephone
508-429-7340
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/aob-pharma-receives-european-medicines-agency-ema-positive-decision-on-the-pediatric-investigation-plan-pip-supporting-future-development-of-b244-for-the-treatment-of-mild-to-moderate-atopic-dermatitis-in-children-adolescent-302627277.html

PR NEWSWIRE
02 Dec 2025

https://www.businesswire.com/news/home/20251007459013/en/Veristat-and-AOBiome-Therapeutics-to-Present-at-Clinical-Outsourcing-Group-on-Essential-Elements-of-Effective-Partnerships-with-CROs

BUSINESSWIRE
07 Oct 2025

https://www.businesswire.com/news/home/20250616203834/en/Veristat-Congratulates-George-Medicines-on-FDA-Approval-of-WIDAPLIK

BUSINESSWIRE
16 Jun 2025

https://www.businesswire.com/news/home/20240529939891/en

BUSINESSWIRE
29 May 2024

https://www.businesswire.com/news/home/20240523499154/en

BUSINESSWIRE
23 May 2024

https://www.businesswire.com/news/home/20240403994873/en

BUSINESSWIRE
03 Apr 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty